BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mansour-Ghanaei F, Taheri A, Froutan H, Ghofrani H, Nasiri-Toosi M, Bagherzadeh AH, Farahvash MJ, Mirmomen S, Ebrahimi-Dariani N, Farhangi E, Pourrasouli Z. Effect of oral naltrexone on pruritus in cholestatic patients. World J Gastroenterol 2006; 12(7): 1125-1128 [PMID: 16534857 DOI: 10.3748/wjg.v12.i7.1125]
URL: https://www.wjgnet.com/1007-9327/full/v12/i7/1125.htm
Number Citing Articles
1
Joseph R Volpicelli, Miriam Fenton. Sustained-release naltrexone formulations for the treatment of alcohol and opioid dependenceFuture Neurology 2006; 1(4): 389 doi: 10.2217/14796708.1.4.389
2
Babina Sanjel, Won-Sik Shim. Recent advances in understanding the molecular mechanisms of cholestatic pruritus: A reviewBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2020; 1866(12): 165958 doi: 10.1016/j.bbadis.2020.165958
3
GVMC Fernando, Nancy Preston. Refractory pruritus from malignant cholestasis: managementBMJ Supportive & Palliative Care 2023; 13(e1): e78 doi: 10.1136/bmjspcare-2019-002051
4
Sonja Ständer, Elke Weisshaar, Thomas A. Luger. Neurophysiological and neurochemical basis of modern pruritus treatmentExperimental Dermatology 2008; 17(3): 161 doi: 10.1111/j.1600-0625.2007.00664.x
5
Nora V. Bergasa. Research in the pruritus of cholestasis: Genetics, behavioral studies, and physiomimetic interorgan modelsMedical Hypotheses 2022; 166: 110925 doi: 10.1016/j.mehy.2022.110925
6
Roger W. Chapman, Kate D. Williamson. Crohn's Disease and Ulcerative Colitis2017; : 531 doi: 10.1007/978-3-319-33703-6_52
7
Mariusz Sikora, Adriana Rakowska, Małgorzata Olszewska, Lidia Rudnicka. The Use of Naltrexone in Dermatology. Current Evidence and Future DirectionsCurrent Drug Targets 2019; 20(10): 1058 doi: 10.2174/1389450120666190318121122
8
Nora V. Bergasa. Update on the Treatment of the Pruritus of CholestasisClinics in Liver Disease 2008; 12(1): 219 doi: 10.1016/j.cld.2007.11.009
9
Andreas E. Kremer, Ronald P.J. Oude Elferink, Ulrich Beuers. Pathophysiology and current management of pruritus in liver diseaseClinics and Research in Hepatology and Gastroenterology 2011; 35(2): 89 doi: 10.1016/j.clinre.2010.10.007
10
Nora V. Bergasa. Pruritus in Primary Biliary Cirrhosis: Pathogenesis and TherapyClinics in Liver Disease 2008; 12(2): 385 doi: 10.1016/j.cld.2008.02.013
11
Keith D. Lindor, M. Eric Gershwin, Raoul Poupon, Marshall Kaplan, Nora V. Bergasa, E. Jenny Heathcote. Primary biliary cirrhosisHepatology 2009; 50(1): 291 doi: 10.1002/hep.22906
12
Shari S. Rogal, Lissi Hansen, Arpan Patel, Nneka N. Ufere, Manisha Verma, Christopher D. Woodrell, Fasiha Kanwal. AASLD Practice Guidance: Palliative care and symptom‐based management in decompensated cirrhosisHepatology 2022; 76(3): 819 doi: 10.1002/hep.32378
13
Rami H. Mahmoud, Sarah G. Brooks, Gil Yosipovitch. Current and emerging drugs for the treatment of pruritus: an update of the literatureExpert Opinion on Pharmacotherapy 2024;  doi: 10.1080/14656566.2024.2349193
14
Sarah Dillon, Joseph D. Tobias. Ondansetron to Treat Pruritus Due to Cholestatic JaundiceThe Journal of Pediatric Pharmacology and Therapeutics 2013; 18(3): 241 doi: 10.5863/1551-6776-18.3.241
15
Nora V. Bergasa. The pruritus of cholestasis: From bile acids to opiate agonists: Relevant after all these yearsMedical Hypotheses 2018; 110: 86 doi: 10.1016/j.mehy.2017.11.002
16
Parth Patel, Keshav Patel, Karan Pandher, Ruqiya Shama Tareen. The Role of Psychiatric, Analgesic, and Antiepileptic Medications in Chronic PruritusCureus 2021;  doi: 10.7759/cureus.17260
17
Joel E. Schlosburg, Dale L. Boger, Benjamin F. Cravatt, Aron H. Lichtman. Endocannabinoid Modulation of Scratching Response in an Acute Allergenic Model: A New Prospective Neural Therapeutic Target for PruritusJournal of Pharmacology and Experimental Therapeutics 2009; 329(1): 314 doi: 10.1124/jpet.108.150136
18
Atsuki Yamamoto, Shoji Kuyama, Chiaki Kamei, Yukio Sugimoto. Characterization of scratching behavior induced by intradermal administration of morphine and fentanyl in miceEuropean Journal of Pharmacology 2010; 627(1-3): 162 doi: 10.1016/j.ejphar.2009.10.066
19
Tejesh Patel, Gil Yosipovitch. Therapy of pruritusExpert Opinion on Pharmacotherapy 2010; 11(10): 1673 doi: 10.1517/14656566.2010.484420
20
Sonja Ständer, Thomas A. Luger. Therapy of Skin Diseases2010; : 235 doi: 10.1007/978-3-540-78814-0_24
21
Negar Faramarzi, Ata Abbasi, Seyed M Tavangar, Marjan Mazouchi, Ahmad R Dehpour. Opioid receptor antagonist promotes angiogenesis in bile duct ligated ratsJournal of Gastroenterology and Hepatology 2009; 24(7): 1226 doi: 10.1111/j.1440-1746.2009.05794.x
22
Andreas E. Kremer. What are new treatment concepts in systemic itch?Experimental Dermatology 2019; 28(12): 1485 doi: 10.1111/exd.14024
23
John Halliday, Roger W. Chapman. Crohn's Disease and Ulcerative Colitis2012; : 579 doi: 10.1007/978-1-4614-0998-4_47
24
Sombat Treeprasertsuk, Udomsak Silachamroon, Srivicha Krudsood, Arun Huntrup, Plengsakoon Suwannakudt, Suparp Vannaphan, Polrat Wilairatana. Ursodeoxycholic acid and artesunate in the treatment of severe falciparum malaria patients with jaundiceJournal of Gastroenterology and Hepatology 2010; 25(2): 362 doi: 10.1111/j.1440-1746.2009.06007.x
25
Ngoc Quan Phan, Jeffrey D. Bernhard, Thomas A. Luger, Sonja Ständer. Antipruritic treatment with systemic μ-opioid receptor antagonists: A reviewJournal of the American Academy of Dermatology 2010; 63(4): 680 doi: 10.1016/j.jaad.2009.08.052
26
Miriam M. Düll, Andreas E. Kremer. Evaluation and Management of Pruritus in Primary Biliary CholangitisClinics in Liver Disease 2022; 26(4): 727 doi: 10.1016/j.cld.2022.06.009
27
Margit Baumann-Köhler, Almut Hartenstein-Pinter, Yvonne Hülsheger. Pädiatrische Palliativversorgung – Schmerzbehandlung und Symptomkontrolle2022; : 231 doi: 10.1007/978-3-662-63148-5_6
28
Wiebke Pirschel, Andreas E. Kremer. Pruritus2016; : 253 doi: 10.1007/978-3-319-33142-3_34
29
Andreas E. Kremer, Jamison Feramisco, Peter W. Reeh, Ulrich Beuers, Ronald P.J. Oude Elferink. Receptors, cells and circuits involved in pruritus of systemic disordersBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2014; 1842(7): 869 doi: 10.1016/j.bbadis.2014.02.007
30
Carolyn Stull, Michael J. Lavery, Gil Yosipovitch. Advances in therapeutic strategies for the treatment of pruritusExpert Opinion on Pharmacotherapy 2016; 17(5): 671 doi: 10.1517/14656566.2016.1127355
31
Kimberly A. Bower, Gerit D. Mulder, Anke Reineke, Shireen V. Guide. Textbook of Interdisciplinary Pediatric Palliative Care2011; : 350 doi: 10.1016/B978-1-4377-0262-0.00035-9
32
Annabel Maruani, Mahtab Samimi, Gérard Lorette. Les prurigosLa Presse Médicale 2009; 38(7-8): 1099 doi: 10.1016/j.lpm.2008.10.014
33
Andreas Binder, Jana Koroschetz, Ralf Baron. Disease mechanisms in neuropathic itchNature Clinical Practice Neurology 2008; 4(6): 329 doi: 10.1038/ncpneuro0806
34
Chalermrat Bunchorntavakul, K. Rajender Reddy. Pruritus in Chronic Cholestatic Liver DiseaseClinics in Liver Disease 2012; 16(2): 331 doi: 10.1016/j.cld.2012.03.010
35
Elliot B. Tapper, Nneka N. Ufere, Daniel Q. Huang, Rohit Loomba. Review article: current and emerging therapies for the management of cirrhosis and its complicationsAlimentary Pharmacology & Therapeutics 2022; 55(9): 1099 doi: 10.1111/apt.16831
36
Juan Pablo Aristizábal Linares, Lester Andrade Almario. Eficacia de la naltrexona en el tratamiento de prurito severoRevista Colombiana de Anestesiología 2011; 39(2): 251 doi: 10.5554/rca.v39i2.91
37
Charles Dervout, Nicholas Boulais, Thomas Barnetche, Jean-Baptiste Nousbaum, Emilie Brenaut, Laurent Misery. Efficacy of Treatments for Cholestatic Pruritus: A Systemic Review and Meta-analysisActa Dermato-Venereologica 2022; 102: adv00653 doi: 10.2340/actadv.v102.310
38
Kazuto Tajiri, Yukihiro Shimizu. Recent advances in the management of pruritus in chronic liver diseasesWorld Journal of Gastroenterology 2017; 23(19): 3418-3426 doi: 10.3748/wjg.v23.i19.3418
39
Santiago Medina Ramírez, Ana Milena Sánchez, Francisco Gómez Oquendo. Sugammadex en un paciente con insuficiencia renal crónicaRevista Colombiana de Anestesiología 2011; 39(3): 433 doi: 10.5554/rca.v39i3.219
40
Nora V. Bergasa. Clinical Cases in Hepatology2022; : 443 doi: 10.1007/978-1-4471-4715-2_15
41
Konstantin Agelopoulos, Manuel Pedro Pereira, Henning Wiegmann, Sonja Ständer. Cutaneous neuroimmune crosstalk in pruritusTrends in Molecular Medicine 2022; 28(6): 452 doi: 10.1016/j.molmed.2022.03.005
42
Emilie Javelle, Philippe Paule, Yves Chabrillat, Edward Lightburn, Thierry Coton, Jean-Jacques Morand. Un prurit traité par implantation d’un pacemakerLa Presse Médicale 2011; 40(9): 885 doi: 10.1016/j.lpm.2011.03.003
43
Carola Xander, Joerg J Meerpohl, Daniel Galandi, Sabine Buroh, Guido Schwarzer, Gerd Antes, Gerhild Becker, Carola Xander. Cochrane Database of Systematic Reviews2013;  doi: 10.1002/14651858.CD008320.pub2
44
Nora V. Bergasa. Cirrhosis: A practical guide to management2015; : 291 doi: 10.1002/9781118412640.ch26
45
Andrea A. Gossard, Keith D. Lindor. Practical Gastroenterology and Hepatology: Liver and Biliary Disease2010; : 87 doi: 10.1002/9781444325249.ch10
46
Puneeta Tandon, Brian H. Rowe, Ben Vandermeer, Vincent G. Bain. The Efficacy and Safety of Bile Acid Binding Agents, Opioid Antagonists, or Rifampin in the Treatment of Cholestasis-Associated PruritusThe American Journal of Gastroenterology 2007; 102(7): 1528 doi: 10.1111/j.1572-0241.2007.01200.x
47
Nora V. Bergasa, Deewan Deewan. Pruritus2010; : 289 doi: 10.1007/978-1-84882-322-8_45
48
Hirsh D. Trivedi, Blanca Lizaola, Elliot B. Tapper, Alan Bonder. Management of Pruritus in Primary Biliary Cholangitis: A Narrative ReviewThe American Journal of Medicine 2017; 130(6): 744.e1 doi: 10.1016/j.amjmed.2017.01.037
49
Waldemar Siemens, Carola Xander, Joerg J Meerpohl, Sabine Buroh, Gerd Antes, Guido Schwarzer, Gerhild Becker. Pharmacological interventions for pruritus in adult palliative care patientsCochrane Database of Systematic Reviews 2016; 2016(11) doi: 10.1002/14651858.CD008320.pub3
50
Stephani L. Stancil, Susan Abdel-Rahman, Jon Wagner. Developmental Considerations for the Use of Naltrexone in Children and AdolescentsThe Journal of Pediatric Pharmacology and Therapeutics 2021; 26(7): 675 doi: 10.5863/1551-6776-26.7.675
51
Juan Trivella, Binu V. John, Cynthia Levy. Primary biliary cholangitis: Epidemiology, prognosis, and treatmentHepatology Communications 2023; 7(6) doi: 10.1097/HC9.0000000000000179
52
Kapil Vyas, Kriti Maheshwari, Praveen K. Shanmugam Reddy, Rajesh Verma, Iffat Hasan, Asit Mittal. Prescription Practices Regarding the use of Systemic Drugs in the Management of Patients with Chronic Pruritus amongst Indian Dermatologists – A Questionnaire Based SurveyIndian Dermatology Online Journal 2024; 15(1): 33 doi: 10.4103/idoj.idoj_500_22
53
F.J. Navarro-Triviño. [Translated article] Pruritus in Dermatology: Part 2—Diseases and Their TreatmentActas Dermo-Sifiliográficas 2023; 114(7): T613 doi: 10.1016/j.ad.2023.06.007
54
Fatima Isa, Grace M. Turner, Geetinder Kaur, Derek Kyte, Anita Slade, Tanya Pankhurst, Larissa Kerecuk, Thomas Keeley, James Ferguson, Melanie Calvert. Patient-reported outcome measures used in patients with primary sclerosing cholangitis: a systematic reviewHealth and Quality of Life Outcomes 2018; 16(1) doi: 10.1186/s12955-018-0951-6
55
Nora V. Bergasa. Opiate Receptors and Antagonists2009; : 551 doi: 10.1007/978-1-59745-197-0_29
56
Andreas E. Kremer, Ronald P. J. Oude-Elferink, Ulrich Beuers. Pruritus2010; : 177 doi: 10.1007/978-1-84882-322-8_28
57
Jacqueline A. G. M. Langedijk, Ulrich H. Beuers, Ronald P. J. Oude Elferink. Cholestasis-Associated Pruritus and Its PruritogensFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.639674
58
Richard J. Bodnar. Endogenous opiates and behavior: 2006Peptides 2007; 28(12): 2435 doi: 10.1016/j.peptides.2007.09.002
59
F.J. Navarro-Triviño. Prurito en dermatología. Enfermedades y su tratamiento. Parte 2Actas Dermo-Sifiliográficas 2023; 114(7): 613 doi: 10.1016/j.ad.2023.03.004
60
Adhyatm Bhandari, Rahul Mahajan. Skin Changes in CirrhosisJournal of Clinical and Experimental Hepatology 2022; 12(4): 1215 doi: 10.1016/j.jceh.2021.12.013
61
Ashley Vander Does, Cynthia Levy, Gil Yosipovitch. Cholestatic Itch: Our Current Understanding of Pathophysiology and TreatmentsAmerican Journal of Clinical Dermatology 2022; 23(5): 647 doi: 10.1007/s40257-022-00710-2
62
Ahmad H. Ali, Elizabeth J. Carey, Keith D. Lindor. Liver Disorders2017; : 251 doi: 10.1007/978-3-319-30103-7_16
63
Fay Louise Murray-Brown. Naltrexone for cholestatic itch: a systematic reviewBMJ Supportive & Palliative Care 2021; 11(2): 217 doi: 10.1136/bmjspcare-2020-002801
64
Elsemieke de Vries, Ruth Bolier, Jorn Goet, Albert Parés, Jef Verbeek, Marleen de Vree, Joost Drenth, Karel van Erpecum, Karin van Nieuwkerk, Frans van der Heide, Nahid Mostafavi, Jeltje Helder, Cyriel Ponsioen, Ronald Oude Elferink, Henk van Buuren, Ulrich Beuers. Fibrates for Itch (FITCH) in Fibrosing Cholangiopathies: A Double-Blind, Randomized, Placebo-Controlled TrialGastroenterology 2021; 160(3): 734 doi: 10.1053/j.gastro.2020.10.001
65
Vishwajit Kode, Kidist K. Yimam. Cholestatic Pruritus: Pathophysiology, Current Management Approach, and Emerging TherapiesCurrent Hepatology Reports 2024; 23(1): 123 doi: 10.1007/s11901-024-00638-7